Nate Edwards of Arya Consulting moderates a discussion with Elisabeth Gardiner of Tevard Biosciences and Donny Xu of the RTW Institute about the regulatory and manufacturing hurdles facing rare disease drug developers.
|Videos|June 30, 2023
Investigating Incubators & Innovation with Mason Ailstock
Author(s)Grant Playter
Mason Ailstock, CEO of the Rowen Foundation, discusses incubators and their potential to promote innovation.
Advertisement
In this video interview, Mason Ailstock, CEO of the Rowen Foundation, talked to Grant Playter, associate editor, on the topic of incubators and their potential to promote innovation.
Rowen is a knowledge community in Metro Atlanta focused on fostering collaboration across industries, including those in the medical, environmental, and agricultural fields. In this interview, Mason touches on the current status of the Rowen Foundation, the importance of fostering collaboration in this manner, and how it can promote innovation in the biopharma industry.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA’s New Inspection Playbook Counts Remote Assessments and MRA Reports Toward Facility Evaluations
2
Improving Oral Peptide Delivery Through Structural Modifications
3
Who Answers for Your Data? Building a Life Sciences Data Mesh
4
Late-Phase Impurities Need Reference Standards: AAPS PharmSci 360 2026
5